Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies

Modlin, 2008, Gastroenteropancreatic neuroendocrine tumours, Lancet Oncol, 9, 61, 10.1016/S1470-2045(07)70410-2 Lawrence, 2011, The epidemiology of gastroenteropancreatic neuroendocrine tumors, Endocrinol Metab Clin North Am, 40, 1, 10.1016/j.ecl.2010.12.005 Frilling, 2014, Recommendations for management of patients with neuroendocrine liver metastases, Lancet Oncol, 15, e8, 10.1016/S1470-2045(13)70362-0 Caplin, 2014, Lanreotide in metastatic enteropancreatic neuroendocrine tumors, N Engl J Med, 371, 224, 10.1056/NEJMoa1316158 Yang, 2014, Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis, Acta Radiol, 55, 389, 10.1177/0284185113496679 Frilling, 2010, The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors, Ann Surg, 252, 850, 10.1097/SLA.0b013e3181fd37e8 Hodul, 2008, Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?, Cancer Control, 15, 314, 10.1177/107327480801500406 Akerstrom, 2004, Surgical treatment of endocrine pancreatic tumours, Neuroendocrinology, 80, 62, 10.1159/000080744 Bodei, 2015, The status of neuroendocrine tumor imaging: from darkness to light?, Neuroendocrinology, 101, 1, 10.1159/000367850 Modlin, 2014, Neuroendocrine tumor biomarkers: current status and perspectives, Neuroendocrinology, 100, 265, 10.1159/000368363 Modlin, 2014, A multianalyte PCR blood test outperforms single analyte ELISAs for neuroendocrine tumor detection, Endocr Relat Cancer, 21, 615, 10.1530/ERC-14-0190 Modlin, 2013, The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood, PLoS One, 8, e63364, 10.1371/journal.pone.0063364 Walenkamp, 2014, Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment, Endocr Relat Cancer, 21, R445, 10.1530/ERC-14-0106 Kidd, 2015, Blood and tissue net gene cluster analysis correlate, define hallmarks and predict disease status, Endocr Relat Cancer, 22, 561, 10.1530/ERC-15-0092 Modlin, 2014, Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility, Clin Chem Lab Med, 52, 419, 10.1515/cclm-2013-0496 Elias, 2010, Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: they are many more than you think, Ann Surg, 251, 307, 10.1097/SLA.0b013e3181bdf8cf Elias, 2003, Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study, Surgery, 133, 375, 10.1067/msy.2003.114 Corless, 2014, Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial, J Clin Oncol, 32, 1563, 10.1200/JCO.2013.51.2046 Norton, 2003, Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study, Ann Surg, 237, 650, 10.1097/01.SLA.0000064375.51939.48 Welin, 2009, Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors, Neuroendocrinology, 89, 302, 10.1159/000179900 Curran, 2011, Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors, Pancreas, 40, 1253, 10.1097/MPA.0b013e318225483c Nykjaer, 2007, Description of patients with midgut carcinoid tumours: clinical database from a Danish centre, In Vivo, 21, 679 Mayo, 2010, Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis, Ann Surg Oncol, 17, 3129, 10.1245/s10434-010-1154-5 Jensen, 2007, Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors, Ann Surg Oncol, 14, 780, 10.1245/s10434-006-9148-z Lawrence, 2012, Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia, BMC Res Notes, 5, 318, 10.1186/1756-0500-5-318